Condition
Panic Attack
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
Early P 1 (1)
Trial Status
Unknown2
Completed2
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06804525Recruiting
LHC-CIDI-5 in Hong Kong
NCT02018497Unknown
Essential Hypotension and Allostasis Registry
NCT02810171Not ApplicableCompleted
Dimensional Brain Behavior Predictors of CBT Outcomes in Pediatric Anxiety
NCT01944423Early Phase 1Completed
Enhancing Panic and Smoking Reduction Treatment With D-Cycloserine
NCT02405052Unknown
Validation of the Panic Screening Score in Patient With Unexplained Chest Pain
Showing all 5 trials